Guangdong Marubi Biotechnology Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 1,211.590 million compared to CNY 1,055.657 million a year ago. Operating income was CNY 427.281 million compared to CNY 278.079 million a year ago. Net income was CNY 359.094 million compared to CNY 235.840 million a year ago. Basic earnings per share from continuing operations was CNY 0.97 compared to CNY 0.66 a year ago.